Literature DB >> 20041307

The analysis of longitudinal quality of life measures with informative drop-out: a pattern mixture approach.

Wendy J Post1, Ciska Buijs, Ronald P Stolk, Elisabeth G E de Vries, Saskia le Cessie.   

Abstract

PURPOSE: The analysis of longitudinal health-related quality of life measures (HRQOL) can be seriously hampered due to informative drop-out. Random effects models assume Missing At Random and do not take into account informative drop-out. We therefore aim to correct the bias due to informative drop-out.
METHODS: Analyses of data from a trial comparing standard-dose and high-dose chemotherapy for patients with breast cancer with respect to long-term impact on HRQOL will serve as illustration. The subscale Physical Function (PF) of the SF36 will be used. A pattern mixture approach is proposed to account for informative drop-out. Patterns are defined based on events related to HRQOL, such as death and relapse. The results of this pattern mixture approach are compared to the results of the commonly used random effects model.
RESULTS: The findings of the pattern mixture approach are well interpretable, and different courses over time in different patterns are distinguished. In terms of estimated differences between standard dose and high dose, the results of both approaches are slightly different, but have no consequences for the clinical evaluation of both doses.
CONCLUSION: Under the assumption that drop-out is at random within the patterns, the pattern mixture approach adjusts the estimates to a certain degree. This approach accounts in a relatively simple way for informative drop-out.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20041307      PMCID: PMC2804788          DOI: 10.1007/s11136-009-9564-1

Source DB:  PubMed          Journal:  Qual Life Res        ISSN: 0962-9343            Impact factor:   4.147


  8 in total

Review 1.  Analysing longitudinal continuous quality of life data with dropout.

Authors:  D Curran; G Molenberghs; N K Aaronson; S D Fossa; R J Sylvester
Journal:  Stat Methods Med Res       Date:  2002-02       Impact factor: 3.021

2.  Directly parameterized regression conditioning on being alive: analysis of longitudinal data truncated by deaths.

Authors:  Brenda F Kurland; Patrick J Heagerty
Journal:  Biostatistics       Date:  2005-04       Impact factor: 5.899

Review 3.  Quality of life in patients undergoing systemic therapy for advanced breast cancer.

Authors:  Andrew Bottomley; Patrick Therasse
Journal:  Lancet Oncol       Date:  2002-10       Impact factor: 41.316

4.  Pattern mixture models for longitudinal quality of life studies in advanced stage disease.

Authors:  Donna K Pauler; Sheryl McCoy; Carol Moinpour
Journal:  Stat Med       Date:  2003-03-15       Impact factor: 2.373

5.  Efficacy of high-dose alkylating chemotherapy in HER2/neu-negative breast cancer.

Authors:  S Rodenhuis; M Bontenbal; Q G C M van Hoesel; W M Smit; M A Nooij; E E Voest; E van der Wall; P Hupperets; H van Tinteren; J L Peterse; M J van de Vijver; E G E de Vries
Journal:  Ann Oncol       Date:  2006-01-30       Impact factor: 32.976

6.  High-dose chemotherapy with hematopoietic stem-cell rescue for high-risk breast cancer.

Authors:  Sjoerd Rodenhuis; Marijke Bontenbal; Louk V A M Beex; John Wagstaff; Dick J Richel; Marianne A Nooij; Emile E Voest; Pierre Hupperets; Harm van Tinteren; Hans L Peterse; Elisabeth M TenVergert; Elisabeth G E de Vries
Journal:  N Engl J Med       Date:  2003-07-03       Impact factor: 91.245

7.  Chemotherapy versus ovarian ablation as adjuvant therapy for breast cancer: impact on health-related quality of life in a randomized trial.

Authors:  Mogens Groenvold; Peter M Fayers; Morten Aagaard Petersen; Henning T Mouridsen
Journal:  Breast Cancer Res Treat       Date:  2006-03-16       Impact factor: 4.872

8.  Prospective study of long-term impact of adjuvant high-dose and conventional-dose chemotherapy on health-related quality of life.

Authors:  Ciska Buijs; Sjoerd Rodenhuis; Caroline M Seynaeve; Quirinus G C M van Hoesel; Elsken van der Wall; Wim J M Smit; Marianne A Nooij; Emile Voest; Pierre Hupperets; Els M TenVergert; Harm van Tinteren; Pax H B Willemse; Marian J E Mourits; Neil K Aaronson; Wendy J Post; Elisabeth G E de Vries
Journal:  J Clin Oncol       Date:  2007-12-01       Impact factor: 44.544

  8 in total
  12 in total

1.  Time to deterioration in quality of life score as a modality of longitudinal analysis in patients with breast cancer.

Authors:  Zeinab Hamidou; Tienhan S Dabakuyo; Mariette Mercier; Jean Fraisse; Sylvain Causeret; Hervé Tixier; Marie-Martine Padeano; Catherine Loustalot; Jean Cuisenier; Jean-Marc Sauzedde; Marc Smail; Jean-Philibert Combier; Patrick Chevillote; Christian Rosburger; Patrick Arveux; Franck Bonnetain
Journal:  Oncologist       Date:  2011-09-23

2.  Durability of quality of life benefits of transcatheter aortic valve replacement: Long-term results from the CoreValve US extreme risk trial.

Authors:  Suzanne J Baron; Suzanne V Arnold; Matthew R Reynolds; Kaijun Wang; Michael Deeb; Michael J Reardon; James Hermiller; Steven J Yakubov; David H Adams; Jeffrey J Popma; David J Cohen
Journal:  Am Heart J       Date:  2017-08-12       Impact factor: 4.749

3.  Health-related quality of life in cancer patients at the end of life, translation, validation, and longitudinal analysis of specific tools: study protocol for a randomized controlled trial.

Authors:  Anne-Lise Poirier; Fabrice Kwiatkowski; Jean-Marie Commer; Bénédicte D'Aillières; Virginie Berger; Mariette Mercier; Franck Bonnetain
Journal:  Trials       Date:  2012-04-20       Impact factor: 2.279

4.  Outcomes of Babies with Opioid Exposure (OBOE): protocol of a prospective longitudinal cohort study.

Authors:  Carla M Bann; Jamie E Newman; Brenda Poindexter; Katherine Okoniewski; Sara DeMauro; Scott A Lorch; Deanne Wilson-Costello; Namasivayam Ambalavanan; Myriam Peralta-Carcelen; Catherine Limperopoulos; Kushal Kapse; Jonathan M Davis; Michele Walsh; Stephanie Merhar
Journal:  Pediatr Res       Date:  2022-08-30       Impact factor: 3.953

Review 5.  Health-related quality of life in patients with brain tumors: limitations and additional outcome measures.

Authors:  Linda Dirven; Jacob C Reijneveld; Neil K Aaronson; Andrew Bottomley; Bernard M J Uitdehaag; Martin J B Taphoorn
Journal:  Curr Neurol Neurosci Rep       Date:  2013-07       Impact factor: 5.081

6.  Comparison of three longitudinal analysis models for the health-related quality of life in oncology: a simulation study.

Authors:  Amélie Anota; Antoine Barbieri; Marion Savina; Alhousseiny Pam; Sophie Gourgou-Bourgade; Franck Bonnetain; Caroline Bascoul-Mollevi
Journal:  Health Qual Life Outcomes       Date:  2014-12-31       Impact factor: 3.186

7.  Construction of quality of life change patterns: example in oncology in a phase III therapeutic trial (FFCD 0307).

Authors:  Gillles Nuemi; Hervé Devilliers; Karine Le Malicot; Rosine Guimbaud; Côme Lepage; Catherine Quantin
Journal:  Health Qual Life Outcomes       Date:  2015-09-22       Impact factor: 3.186

Review 8.  Improving Outcomes in Patients with CRC: The Role of Patient Reported Outcomes-An ESDO Report.

Authors:  Eric Van Cutsem; Aimery De Gramont; Geoffrey Henning; Philippe Rougier; Franck Bonnetain; Thomas Seufferlein
Journal:  Cancers (Basel)       Date:  2017-05-26       Impact factor: 6.639

Review 9.  The importance of patient-reported outcomes in clinical trials and strategies for future optimization.

Authors:  Rebecca Mercieca-Bebber; Madeleine T King; Melanie J Calvert; Martin R Stockler; Michael Friedlander
Journal:  Patient Relat Outcome Meas       Date:  2018-11-01

10.  Evaluation of parameters in mixed male DNA profiles for the Identifiler® multiplex system.

Authors:  Na Hu; Bin Cong; Tao Gao; Rong Hu; Yi Chen; Hui Tang; Luyan Xue; Shujin Li; Chunling Ma
Journal:  Int J Mol Med       Date:  2014-05-12       Impact factor: 4.101

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.